Goldman Sachs Group Inc Hutchmed (China) LTD Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 111,887 shares of HCM stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,887

Previous 52,494 113.14%

Holding current value

$1.67 Million

Previous $898,000 143.54%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.03 - $20.31 $952,069 - $1.21 Million	59,393 Added 113.14%	111,887 $2.19 Million
Q2 2024 Aug 13, 2024	SELL	$16.36 - $21.78 $145,538 - $193,754	-8,896 Reduced 14.49%	52,494 $898,000
Q1 2024 May 15, 2024	SELL	$12.08 - $18.56 $5 Million - $7.68 Million	-413,980 Reduced 87.09%	61,390 $1.03 Million
Q4 2023 Feb 13, 2024	BUY	$16.25 - $20.23 $1.02 Million - $1.27 Million	62,762 Added 15.21%	475,370 $8.61 Million
Q3 2023 May 14, 2024	SELL	$11.85 - $16.95 $743,729 - $1.06 Million	-62,762 Reduced 13.2%	412,608 $6.99 Million
Q3 2023 Nov 14, 2023	SELL	$11.85 - $16.95 $1.54 Million - $2.2 Million	-130,075 Reduced 23.97%	412,608 $6.99 Million
Q2 2023 May 14, 2024	BUY	$10.78 - $17.73 $3.09 Million - $5.08 Million	286,610 Added 111.93%	542,683 $6.51 Million
Q2 2023 Aug 14, 2023	BUY	$10.78 - $17.73 $3.09 Million - $5.08 Million	286,610 Added 111.93%	542,683 $6.51 Million
Q1 2023 May 14, 2024	SELL	$13.02 - $19.87 $7.83 Million - $12 Million	-601,698 Reduced 70.15%	256,073 $3.33 Million
Q1 2023 May 11, 2023	SELL	$13.02 - $19.87 $7.83 Million - $12 Million	-601,698 Reduced 70.15%	256,073 $3.33 Million
Q4 2022 May 14, 2024	BUY	$7.65 - $15.51 $3.27 Million - $6.63 Million	427,226 Added 99.23%	857,771 $12.7 Million
Q4 2022 Feb 13, 2023	BUY	$7.65 - $15.51 $3.27 Million - $6.63 Million	427,226 Added 99.23%	857,771 $12.7 Million
Q3 2022 May 14, 2024	SELL	$8.63 - $15.52 $30.1 Million - $54.1 Million	-3,482,742 Reduced 89.0%	430,545 $3.82 Million
Q3 2022 Nov 10, 2022	SELL	$8.63 - $15.52 $30.1 Million - $54.1 Million	-3,482,742 Reduced 89.0%	430,545 $3.81 Million
Q2 2022 May 14, 2024	BUY	$8.59 - $20.77 $29.5 Million - $71.4 Million	3,437,917 Added 723.21%	3,913,287 $49.5 Million
Q2 2022 Aug 15, 2022	BUY	$8.59 - $20.77 $30.8 Million - $74.5 Million	3,586,271 Added 1096.67%	3,913,287 $49.5 Million
Q1 2022 May 16, 2022	SELL	$15.52 - $35.65 $3.98 Million - $9.15 Million	-256,658 Reduced 43.97%	327,016 $6.19 Million
Q4 2021 Feb 14, 2022	SELL	$28.89 - $35.33 $762,233 - $932,146	-26,384 Reduced 4.32%	583,674 $20.5 Million
Q3 2021 Nov 10, 2021	BUY	$35.66 - $42.94 $21.8 Million - $26.2 Million	610,058 New	610,058 $22.3 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

6.88M

Call Options Held

6.2K

Put Options Held

1.1K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.58B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Hutchmed (China) LTD Transaction History